Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women-Reference-Cited by-同舟云学术

Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women

Published:2017-09-26 Issue:12 Volume:45 Page:1065-1072
ISSN:8755-1039
Container-title:Diagnostic Cytopathology
language:en
Short-container-title:Diagnostic Cytopathology

Author:

Granados Rosario¹^ORCID,Tellez-Safina Hilda²,Solis Isabel³,Mateos Francisco³,Rodriguez-Barbero Jose Maria¹,Aramburu Jose Antonio¹,Huertas Miguel Angel³,Bajo Paloma¹,Camarmo Encarnacion¹,Corrales Teresa¹,Medina Pedro⁴,Calvo Beatriz⁵,Martin Esther⁵,Anta Laura⁵,Zamora Manuel⁵,Alcaide Teresa⁵

Affiliation:

1. Department of Pathology; Hospital Universitario de Getafe; Madrid Spain

2. Department of Pathology; Hospital Universitario de Fuenlabrada; Madrid Spain

3. Department of Gynecology; Hospital Universitario de Getafe; Madrid Spain

4. Direccion Asistencial Norte Madrid, Primary Care; Alfonso Rodriguez Castelao 17 Madrid

5. Direccion Asistencial Sur Madrid, Primary Care; Juan de la Cierva s/n Getafe

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Reference40 articles.

1. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials;Ronco;Lancet.,2014